TOPALOĞLU, R. Et Al. 2019. Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. FRONTIERS IN PEDIATRICS , vol.7 .

TOPALOĞLU, R., GÜLHAN, B., Celegen, K., Inozu, M., Hayran, M., Duzoya, A., ... ÖZALTIN, F.(2019). Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. FRONTIERS IN PEDIATRICS , vol.7.

TOPALOĞLU, REZAN Et Al. "Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth," FRONTIERS IN PEDIATRICS , vol.7, 2019

TOPALOĞLU, REZAN Et Al. "Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth." FRONTIERS IN PEDIATRICS , vol.7, 2019

TOPALOĞLU, R. Et Al. (2019) . "Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth." FRONTIERS IN PEDIATRICS , vol.7.

@article{article, author={REZAN TOPALOĞLU Et Al. }, title={Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth}, journal={FRONTIERS IN PEDIATRICS}, year=2019}